A Biological Theory of Attention Control in the Framework of Rational Meta-Reasoning
- Institution
- COLUMBIA UNIVERSITY HEALTH SCIENCES, NY
- Principal investigator
- Jacqueline Gottlieb
- Funding
- $370K
- Duration
- 2024–2026
Moonbase score
Still being scored
Abstract
Summary Attending to informative stimuli is critical for choosing appropriate actions, but the biological mechanisms underlying this ability are not well understood. Recent theoretical models of computational rationality propose that an executive meta-level controller regulates the precision of a cognitive process (e.g., learning or memory) based on the estimated costs and benefits of the process in a particular context. However, current models have yet to account for the control of attention to obtain information (reduce uncertainty) and have been limited to mathematical formalisms rather than biologically plausible architectures. In a Targeted BRAIN Circuits R01, we will fill these gaps by investigating the cellular and neuromodulatory mechanisms of attention control in visual and executive structures – i.e., the monkey lateral intraparietal area (LIP) and anterior cingulate cortex (ACC) – in conjunction with a neurocognitive model developed by the PIs, the attention reinforcement meta-learner (A- RML). We will test the novel hypotheses that (1) stimuli compete for control of saccades based on their diagnosticity (predictive accuracy about future events) and the competition is sharpened in favor of more diagnostic predictors by higher decision uncertainty and (2) dACC and LIP, and DA and NE have distinct roles in, respectively, the valuation and implementation of an attentional policy. In the current planning proposal, we set the stage for this goal providing behavioral evidence for our hypothesis (Aim 1), and (2) establishing the feasibility of using, in monkeys, novel fluorescent molecular sensors – GRAB – that have been demonstrated in rodents to measure neurotransmitter release with much greater temporal and pharmacological specificity relative to current techniques (Aim 2). In the full RO1 we will use these tools to obtain high precision measurements of neuromodulator release in relation to information gathering and neural activity, validate and further extend the A-RML based on empirical observations, and interrogating the circuit using causal manipulations. The results will provide a novel account of attention control that spans cellular and neuromodulatory mechanisms and a computational account linking attention with Bayesian theories of uncertainty minimization.
Research team
- Vincent P FerreraPI
- Jacqueline GottliebPI
LOADING MOONBASE SCORE
Questions for COLUMBIA UNIVERSITY HEALTH SCIENCES
Answered by the team behind this research.
No questions yet. Sign in to ask the first one
Related grants
Same institution, same topic, scored first.
- NIH · Columbia University Health Sciences70
Causal Gene Prioritization in Systemic Sclerosis: Multi-Omics Analyses from Population Genetics to Single Cell Biology
Yiming Luo · $173K · 2025–2030
- NIH · Columbia University Health Sciences48
Metformin in Alzheimer's dementia Prevention (MAP)
Daniel F Hanley · $6.5M · 2019–2026
- NIH · Columbia University Health Sciences47
Quantifying Error Growth to Improve Infectious Disease Forecast Accuracy
Jeffrey L Shaman · $659K · 2021–2027